Quotes

Detailed quotes and news stories about the stocks or ETFs featured in thousands of newsletter articles by MoneyShow.com experts serve as an outstanding resource for the latest outperforming picks, high-probability trade set-ups, and actionable recommendations.

Quote Chart News Company Profile Price History

Trending Now


Filter By Category
Filter By Keywords
Stocks slid again yesterday amid ongoing tariff turmoil – and they’re modestly weaker this morning, too. Gold and silver are continuing to rally strongly, while crude oil and the dollar are flattish. Treasuries are higher.
Sem-EES. And Sem-EYES. Both serve as good economic and market indicators. Unfortunately, neither looks encouraging here.
It seems like we're about to learn where that fine line is between encouraging more auto production (both finished product and parts) to come back to the US — and still making cars/trucks that Americans can afford to buy. You need the latter in order to make the former viable, advises Peter Boockvar, editor of The Boock Report.
Most investors chase AI, semiconductors, and the latest crypto buzz. But one of the most explosive trades of the year is hiding in plain sight. That trade? Copper, writes Nicholas Vardy, editor of The Global Guru.
Gold ripped through $3,000 an ounce, and that trade was a home run. The question now? What’s next? Take a look at the iShares Silver Trust (SLV), suggests JC Parets, founder of AllStarCharts.
Is it a retracement or trend reversal? If we knew the answer to that question unequivocally, we would be sitting on a beach in Tahiti. Instead, you have the next best thing: My take on what constitutes a retracement verses a trend reversal and why clarity on this is crucial, advises Hugh Grossman, founder of DayTradeSPY.
Want to know why most traders lose money — and how you can avoid the same fate? In this episode of the MoneyShow MoneyMasters Podcast, I’m joined by Brian Shannon, veteran trader and founder of Alphatrends.net.
Bristol-Myers Squibb Co. (BMY) traces its corporate beginnings back to 1887. Today, the company is a leader in developing innovative drugs like Eliquis for stroke prevention and Opdivo for cancer immunotherapy, writes Ben Reynolds, editor of Sure Retirement.
I’m back behind my desk after participating in the Swiss Mining Institute’s March Conference. While gold may be at the start of a mild near-term correction after becoming overbought, silver is looking less overbought and may hold up, advises Peter Krauth, editor of Silver Stock Investor.
Stocks remain stuck in the mud, following the recent 10% correction and the partial recovery since. Crude oil is a bit higher along with gold and silver, while Treasuries are down modestly. Bitcoin is holding in the high-$80,000s.
Did you get a load of the latest consumer confidence figures? Woof!
Loading...